Of the T2D patients, 66% (n = 23) were treated with metformin (19 only metformin and 4 metformin with insulin), 6% (n = 2) with other oral T2D medication, 3% (n = 1) with insulin alone, 23% (n = 8) were not receiving medication for T2D and for one patient the information of T2D treatments was missing. This evidence concerns the gene INS and type 2 diabetes mellitus.